Ignite Creation Date:
2024-05-05 @ 11:20 AM
Last Modification Date:
2024-10-26 @ 9:03 AM
Study NCT ID:
NCT00003425
Status:
COMPLETED
Last Update Posted:
2013-04-26
First Post:
1999-11-01
Brief Title:
Phase III Study of Escalating-Dose Melphalan wAutologous SCS Amifostine Cytoprotect
Sponsor:
University of Kentucky
Organization:
University of Kentucky
Organization Data
Organization:
University of Kentucky
Class:
OTHER
Study ID:
UKMC-97BMT72
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
University of Kentucky
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None